ASR Vermogensbeheer’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
6,692
+3,120
+87% +$820K 0.02% 366
2026
Q1
$953K Buy
3,572
+199
+6% +$53.9K 0.01% 429
2025
Q4
$846K Sell
3,373
-20
-0.6% -$5.31K 0.01% 450
2025
Q3
$974K Buy
3,393
+9
+0.3% +$2.41K 0.01% 436
2025
Q2
$888K Buy
3,384
+592
+21% +$144K 0.01% 455
2025
Q1
$650K Buy
+2,792
New +$678K 0.01% 463

Other funds holding LH

ASR Vermogensbeheer's LH Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Labcorp (LH) stake by 87% in Q2 2026, buying an estimated $820K and bringing the position to 6,692 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #366.

ASR Vermogensbeheer first reported a position in LH in Q1 2025 and has held it in 6 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • ASR Vermogensbeheer held 6,692 shares of Labcorp worth $1.87M as of Q2 2026.
  • ASR Vermogensbeheer bought 3,120 Labcorp shares in Q2 2026, an estimated $820K.
  • Labcorp made up 0.02% of ASR Vermogensbeheer's portfolio in Q2 2026, its #366 holding.
  • ASR Vermogensbeheer first reported a position in Labcorp in Q1 2025 and has held it in 6 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.